We love #ubiquitin. Lab researching ubiquitination in health and disease @WEHI-research. Posts are by Komander lab members.
Komander Lab
Loading...
And more cool papers in the pipeline, so looking forward to an exciting 2026!
Check out our latest paper on the ubiquitination of glycogen in cells and tissues! Congratulations to Marco Jochem (@marcojochem.bsky.social) and Simon Cobbold for leading this study and to collaborators @craigagoodman1.bsky.social, @pgregorevic.bsky.social, Kai Hofmann and Thomas Hermanns.
A big year for the lab!
We hosted Australia’s first ubiquitin summit in Lorne,
Published the structure of PINK1 on a mitochondrial translocase array,
Reported a new PLpro inhibitor for long COVID,
Celebrated 3 PhD and 1 honours completions,
Went on a lab footy trip, 🏈
Won the Eureka prize!! 🏆
Komander Lab
Congratulations Jake @mediocre-jake.bsky.social, Bekky Feltham and team on their phenomenal effort in putting together the E3-ome, published in Cell www.cell.com/cell/fulltex....
An extremely valuable resource for ubiquitin researchers.
Out now! The latest paper from the lab, spearheaded by Philipp Schenk, describing a new USP9X inhibitor with a unique DUB binding site.
Today we have Brenda Schulman, Director of the Department of Molecular Machines and Signalling at Max Planck Institute of Biochemistry, as our interviewee at #AusUb2025. Jump in to find out her research focus and conference tips!
It’s hard to believe that #AusUb2025 has already come to an end 😢. Don’t worry though - we’ll still be posting our speaker interviews in the next couple of days.
Here’s what Sonja Lorenz thought of the Australian Ubiquitin Summit. 👇
Komander Lab
After a long (but fun!) postdoc journey, I am very excited to share that I will start my own lab in the Ubiquitin Signalling Division at WEHI. We will study how ubiquitin controls mitochondrial health and its role in neurodegenerative disease. Hiring soon!
